Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nuance Investments Dumps $38 Million in Henry Schein ( NASDAQ: HSIC ) Shares: Should Investors Sell Too?
NUANCE Investments, LLC reported a significant reduction in its Henry Schein position, selling 494,249 shares and reducing exposure by $38.20 million for Q3 2025, according to a November 5, 2025, SEC filing.According to an SEC filing dated November 5, 2025, NUANCE Investments, LLC disclosed the ...
Here's Why Henry Schein ( HSIC ) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Henry Schein ( HSIC ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Chipotle Is 'Too Expensive,' Cramer Says; Buy This Plane Maker - Bloom Energy ( NYSE:BE ) , Boeing ( NYSE:BA )
On CNBC's "Mad Money Lightning Round," Jim Cramer said Chipotle Mexican Grill, Inc. ( NYSE:CMG ) is "too expensive." Chipotle, on Oct. 29, reported quarterly earnings of 29 cents per share, in line with the analyst consensus estimate.
Henry Schein Raises Outlook, Expands Partnership - Henry Schein ( NASDAQ:HSIC )
Henry Schein Inc. ( NYSE:HSIC ) reported on Tuesday that its third-quarter adjusted earnings were $1.38, up 13.1% year over year, beating the consensus of $1.28. Sales totaled $3.34 billion, surpassing the consensus estimate of $3.28 billion.
Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday - Expeditors International ( NYSE:EXPD ) , Fabrinet ( NYSE:FN )
U.S. stocks were lower, with the Nasdaq Composite falling more than 350 points on Tuesday. Shares of Henry Schein Inc ( NASDAQ:HSIC ) rose sharply during Monday's session after the company reported third-quarter results that beat estimates and raised its full-year EPS and sales guidance.
HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up
Henry Schein's Q3 earnings and revenues top estimates, lifting the stock as the company raised its 2025 outlook on solid business momentum.
Henry Schein ( HSIC ) Q3 Earnings and Revenues Beat Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of +8.66% and +2.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson ( MCK ) Reports Next Week: Wall Street Expects Earnings Growth
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein ( HSIC ) Earnings Expected to Grow: Should You Buy?
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Henry Schein Is Placed Ahead of Q3 Earnings
HSIC heads into Q3 with solid gains expected across Dental, Specialty and Tech segments, though earnings estimates have slipped slightly.
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica's Commercialization Strategy ...
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S. - Henry Schein ( NASDAQ:HSIC ) , Biomerica ( NASDAQ:BMRA )
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors - Relationship Marks a Key Milestone in Biomerica's Commercialization Strategy
Peering Into Henry Schein Inc's Recent Short Interest - Henry Schein ( NASDAQ:HSIC )
Henry Schein Inc's ( NYSE:HSIC ) short interest as a percent of float has risen 7.35% since its last report. According to exchange reported data, there are now 9.23 million shares sold short, which is 8.47% of all regular shares that are available for trading.
Young Innovations Introduces American Eagle Instruments® XP² to the U.S. Market
Algonquin, IL, Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- Young Innovations, Inc. ( "Young" ) , a leading global manufacturer and distributor of dental products, has announced the launch of XP², a proprietary, scientifically driven, next generation line of innovative sharpen-free scalers by American ...
Henry Schein Sees Steady Smile As Dental Market Growth Holds - Henry Schein ( NASDAQ:HSIC )
Henry Schein Inc HSIC brass say global dental market growth remains steady, flat to low-single digits by region. The company's management reaffirmed its expectations for dental equipment growth in the second half.
SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?
Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Albemarle ( NYSE:ALB ) , Domo ( NASDAQ:DOMO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Canaccord Genuity analyst Kingsley Crane upgraded Okta, Inc.
Twilio ( TWLO ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Aug. 7, 2025, 5 p.m. ETChief Executive Officer - Khozema ShipchandlerContinue reading ...
Henry Schein ( HSIC ) Q2 EPS Drops 11%
Henry Schein ( NASDAQ:HSIC ) , a healthcare solutions company focused on distributing dental and medical products, released its quarterly results on August 5, 2025. The quarter's most notable development was a drop in profitability, as both GAAP diluted EPS ( $0.70 ) and non-GAAP diluted EPS ( ...
Why Is Henry Schein Stock Falling Tuesday? - Henry Schein ( NASDAQ:HSIC )
Q2 EPS of $1.10 missed estimates by $0.10; revenue rose 3.3% to $3.34 billion, topping expectations. The company sees over $100 million in annual savings from restructuring, affirms 2025 EPS and revenue guidance. Get special access to three exclusive "Top 10 Stocks" power lists today, updated ...
Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top
HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.
Henry Schein ( HSIC ) Q2 Earnings Lag Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of -6.78% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson ( MCK ) Earnings Expected to Grow: Should You Buy?
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein ( HSIC ) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein to Report Q2 Earnings: What's in Store for the Stock?
HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday - Henry Schein ( NASDAQ:HSIC ) , Imax ( NYSE:IMAX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Deutsche Bank raised Nasdaq, Inc. NDAQ price target from $97 to $105.
This Norfolk Southern Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Darling Ingredients ( NYSE:DAR ) , Dow ( NYSE:DOW )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Ben Kallo downgraded Darling Ingredients Inc.
What Does the Market Think About Henry Schein? - Henry Schein ( NASDAQ:HSIC )
Henry Schein's HSIC short percent of float has fallen 9.66% since its last report. The company recently reported that it has 7.24 million shares sold short, which is 6.64% of all regular shares that are available for trading.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Henry Schein ( NASDAQ:HSIC ) , Best Buy Co ( NYSE:BBY )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Piper Sandler analyst Peter Keith downgraded the rating for Best Buy Co., Inc.
Why Henry Schein ( HSIC ) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.
What Does the Market Think About Henry Schein? - Henry Schein ( NASDAQ:HSIC )
Henry Schein's HSIC short percent of float has risen 19.87% since its last report. The company recently reported that it has 7.89 million shares sold short, which is 7.24% of all regular shares that are available for trading.
Henry Schein ( HSIC ) Up 6.5% Since Last Earnings Report: Can It Continue?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now?
Solventum beats Q1 estimates, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.
The Smart Money Is Buying These 10 Stocks - Apollo Global Management ( NYSE:APO ) , AppLovin ( NASDAQ:APP )
Private equity titans like Apollo, Blackstone and KKR have to reveal what stocks they own every quarter. Copying their investments has beaten the markets 4-to-1 since 2001. Here are KKR's top ten public holdings.
Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up
VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests in the first quarter of 2025.
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results - Henry Schein ( NASDAQ:HSIC )
Henry Schein Inc. HSIC reported mixed results for its first-quarter on Monday. The company posted adjusted EPS of $1.15, up 4.5% year over year, beat the consensus of $1.11. Sales were $3.17 billion, missing the consensus of $3.23 billion.
Clear Aligners Market Size Projected to Surge $21.75 Billion Growth by 2031, With CAGR of 18.8% | The Insight Partners
US & Canada, May 05, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global clear aligners market is growing owing to the increasing prevalence of dental problems such as malocclusion and surging demand for dental aesthetic solutions.
Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals - Henry Schein ( NASDAQ:HSIC )
Q1 adjusted EPS rose 4.5% to $1.15, topping estimates; sales of $3.17 billion missed the $3.23 billion consensus. Global Specialty Products sales rose 4.3% in constant currency, driven by implants, biomaterials, and acquisitions. Feel unsure about the market's next move?
Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls
HSIC ends the first quarter of 2025 on a mixed note.
Henry Schein ( HSIC ) Q1 Earnings Beat Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of 3.60% and 1.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Bon Natural Life ( NASDAQ:BON ) , Cummins ( NYSE:CMI )
U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Futures of major benchmark indices were lower in premarket. The S&P 500 index notched a nine-day advance for the first time since November 2004 on Friday.
Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday - Ford Motor ( NYSE:F ) , Cummins ( NYSE:CMI )
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Tyson Foods Inc. TSN to report quarterly earnings at 82 cents per share on revenue of $13.14 billion before the opening bell, according to data ...
McKesson ( MCK ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Becton Dickinson ( BDX ) Q2 Earnings Top Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of 2.13% and 1.74%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
